US Stocks
Lantern Pharma Inc
Lantern Pharma Inc

Lantern Pharma Inc (LTRN)








Key Stats

Today Low/High
10.06 / 10.43
52 Week Low/High
$11.27 / $24.84
Market Cap

Company Details

Lantern Pharma (LTRN) is a clinical-stage biopharmaceutical company innovating the repurposing, revitalization and development of precision therapeutics in oncology. It leverages advances in machine learning, genomics, and artificial intelligence by using a proprietary A.I. platform to discover biomarker signatures that help identify patients more likely to respond to its pipeline of cancer therapeutics. Lantern's focus is to improve the outcome for patients by leveraging its technology to uncover, rescue and develop abandoned or failed drugs. Its current pipeline of three drugs, with two programs in clinical stages and two in preclinical, focuses on cancers that have unique and unmet clinical needs with a clearly defined patient population. It believes that the use of machine learning, genomics and computational methods can help accelerate the revitalization, refocusing and development of small molecule-based therapies. By targeting drugs to patients whose genomic profile identifies them as having the highest probability of benefiting from the drug, this approach represents the potential to deliver best-in-class outcomes. Its team seeks out experienced industry partners, world-class scientific advisors, and innovative clinical-regulatory approaches to assist in delivering cancer therapies to patients as quickly and efficiently as possible.
Lantern Pharma Inc
Commercial Services

Discover more

Frequently Asked Questions

What is Lantern Pharma Inc (LTRN) share price today?

Can Indians buy Lantern Pharma Inc (LTRN) shares?

How can I buy Lantern Pharma Inc (LTRN) shares from India?

Can Fractional shares of Lantern Pharma Inc (LTRN) be purchased?

What are the documents required to start investing in Lantern Pharma Inc (LTRN) stocks?

We are a SEBI registered investement advisor